Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crispin T Hiley

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature|January 14, 2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature Communications|June 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doublingSebastijan Hobor, Maise Al Bakir, Crispin T Hiley, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature|April 13, 2023
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNAChristopher Abbosh, Alexander M Frankell, Thomas Harrison, et al.
Nature Cancer|August 18, 2020
The T cell differentiation landscape is shaped by tumour mutations in lung cancerEhsan Ghorani, James L Reading, Jake Y Henry, et al.
Nature Medicine|April 12, 2023
Evolutionary characterization of lung adenocarcinoma morphology in TRACERxTakahiro Karasaki, David A Moore, Selvaraju Veeriah, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
The New England Journal of Medicine|April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung CancerMariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature|January 14, 2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature Communications|June 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doublingSebastijan Hobor, Maise Al Bakir, Crispin T Hiley, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature|April 13, 2023
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNAChristopher Abbosh, Alexander M Frankell, Thomas Harrison, et al.
Nature Cancer|August 18, 2020
The T cell differentiation landscape is shaped by tumour mutations in lung cancerEhsan Ghorani, James L Reading, Jake Y Henry, et al.
Nature Medicine|April 12, 2023
Evolutionary characterization of lung adenocarcinoma morphology in TRACERxTakahiro Karasaki, David A Moore, Selvaraju Veeriah, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
The New England Journal of Medicine|April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung CancerMariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
Pageof 5